Edwards Lifesciences Corp (EW)

Total asset turnover

		Dec 31, 2024	Sep 30, 2024	Jun 30, 2024	Mar 31, 2024	Dec 31, 2023	Sep 30, 2023	Jun 30, 2023	Mar 31, 2023	Dec 31, 2022	Sep 30, 2022	Jun 30, 2022	Mar 31, 2022	Dec 31, 2021	Sep 30, 2021	Jun 30, 2021	Mar 31, 2021	Dec 31, 2020	Sep 30, 2020	Jun 30, 2020	Mar 31, 2020
Revenue (ttm)	US$ in thousands	5,724,300	5,872,600	5,999,100	6,143,400	6,004,800	5,819,000	5,657,100	5,500,800	5,382,400	5,363,800	5,355,000	5,357,100	5,232,500	5,094,500	4,925,200	4,474,200	4,386,300	4,368,700	4,321,800	4,483,700
Total assets	US$ in thousands	13,055,300	12,971,200	10,099,300	9,736,300	9,363,200	9,370,800	9,004,000	8,651,200	8,292,500	8,638,200	8,425,100	8,419,900	8,502,600	8,160,300	7,662,100	7,213,700	7,237,100	6,800,800	6,424,100	6,076,100
Total asset turnover		0.44	0.45	0.59	0.63	0.64	0.62	0.63	0.64	0.65	0.62	0.64	0.64	0.62	0.62	0.64	0.62	0.61	0.64	0.67	0.74

December 31, 2024 calculation

Total asset turnover = Revenue (ttm) ÷ Total assets
= $5,724,300K ÷ $13,055,300K
= 0.44

The total asset turnover ratio indicates Edwards Lifesciences Corp's efficiency in generating revenue from its total assets. From the data provided, we observe a declining trend in the total asset turnover ratio, starting at 0.74 on March 31, 2020, and decreasing to 0.44 by December 31, 2024.

This decreasing trend suggests a potential inefficiency in utilizing the company's assets to generate revenue over the period under consideration. A lower total asset turnover ratio may imply that the company is facing challenges in effectively converting its assets into sales.

It is essential for Edwards Lifesciences Corp to closely monitor and improve its asset management practices to enhance its efficiency in generating revenue from its total assets. Further analysis of the factors contributing to this decline in the total asset turnover ratio may provide valuable insights for strategic decision-making to optimize the company's asset utilization and overall financial performance.